Journal
/
/
Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
JoVE Journal
Immunology and Infection
This content is Free Access.
JoVE Journal Immunology and Infection
Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
DOI:

11:31 min

August 08, 2012

, ,

Chapters

  • 00:05Title
  • 01:16Generation of Short-term Human Antigen-specific CD8 T Cell Lines
  • 02:55Preparation of Breast Cancer Cells
  • 04:19Co-culture of Tumor with CD8 T Cells
  • 05:45Chromium Release Assay (CRA)
  • 07:21HER-2/neu p369-specific T Cell / SKBR3 Breast Cancer Cells Co-cultures
  • 11:09Conclusion

Summary

Automatic Translation

The chromium release assay, a common assay for detecting cytotoxic T cell activity, has several limitations. Using antigen-specific CD8 T cells and the human breast cancer tumor line, SKBR3, in the present article, an impedance-based approach was examined for the capability of detecting cell killing.

Related Videos

Read Article